Enflonsia (clesrovimab-cfor) approved to prevent RSV in newborns and infants
seen at 14:54, 22 April in News and communications.Enflonsia (clesrovimab-cfor) approved to prevent RSV in newborns and infants
seen at 14:54, 22 April in News and communications.